Literature DB >> 19329938

Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.

Hidetsugu Yamagishi1, Hirokazu Fukui, Akira Sekikawa, Tokuyuki Kono, Shigehiko Fujii, Kazuhito Ichikawa, Shigeki Tomita, Johji Imura, Hideyuki Hiraishi, Tsutomu Chiba, Takahiro Fujimori.   

Abstract

Regenerating gene family members 1 (REG Ialpha) and 4 (REG IV) are overexpressed in a subset of gastric cancers. However, comparative characterization of the expression of these family proteins has remained unclear. Therefore, we aimed to elucidate not only the association between REG protein expression and mucin phenotype but also their significance as a prognostic marker for patients with gastric cancer. The expression of REG Ialpha, REG IV, CDX2, MUC2, and MUC5AC in gastric cancer tissues was examined by immunohistochemistry. The relationship between REG protein expression and clinicopathological parameters or mucin phenotype was then analyzed. REG Ialpha and REG IV expression was positive in 33 (52%) and 31 (49%) of 63 gastric cancers examined, respectively. REG Ialpha expression was significantly related to venous invasion and tumor stage, whereas REG IV expression showed no relationship to clinicopathological features. With regard to mucin phenotype, REG IV expression was significantly correlated with MUC2 and CDX2 expression, suggesting an association with the intestinal mucin phenotype of gastric cancer. On the other hand, REG Ialpha expression had no correlation with MUC2, CDX2, or MUC5AC in gastric cancer tissues. Expression of REG Ialpha but not REG IV was an independent predictor of poor outcome in patients with gastric cancer. In addition, patients with gastric cancer negative for both REG Ialpha and REG IV expression had a significantly better outcome than patients positive for either REG Ialpha or REG IV. Profiling of REG protein expression is useful to for prognostication of patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329938     DOI: 10.1038/modpathol.2009.41

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  19 in total

1.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

2.  The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.

Authors:  Yun-Suhk Suh; Hyuk-Joon Lee; Eun-Jung Jung; Min-A Kim; Ki Taek Nam; James R Goldenring; Han-Kwang Yang; Woo Ho Kim
Journal:  Ann Surg Oncol       Date:  2011-11-03       Impact factor: 5.344

3.  Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.

Authors:  Li-Sha Ying; Jiang-Liu Yu; Xiao-Xiao Lu; Zhi-Qiang Ling
Journal:  Dig Dis Sci       Date:  2012-09-26       Impact factor: 3.199

4.  Expression profile of the REG gene family in colorectal carcinoma.

Authors:  Hua-chuan Zheng; Akira Sugawara; Hiroshi Okamoto; Shin Takasawa; Hiroyuki Takahashi; Shinji Masuda; Yasuo Takano
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

5.  Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis.

Authors:  Mindy Porterfield; Peng Zhao; Haiyong Han; John Cunningham; Kazuhiro Aoki; Daniel D Von Hoff; Michael J Demeure; J Michael Pierce; Michael Tiemeyer; Lance Wells
Journal:  J Proteome Res       Date:  2013-12-12       Impact factor: 4.466

Review 6.  The Potential Role of REG Family Proteins in Inflammatory and Inflammation-Associated Diseases of the Gastrointestinal Tract.

Authors:  Chao Sun; Xiaoyu Wang; Yangyang Hui; Hirokazu Fukui; Bangmao Wang; Hiroto Miwa
Journal:  Int J Mol Sci       Date:  2021-07-03       Impact factor: 5.923

7.  Oncogenic reg IV is a novel prognostic marker for glioma patient survival.

Authors:  Qi Wang; Jianping Deng; Jun Yuan; Liang Wang; Zhenwei Zhao; Shiming He; Yongsheng Zhang; Yanyang Tu
Journal:  Diagn Pathol       Date:  2012-06-19       Impact factor: 2.644

8.  Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.

Authors:  Leping Yang; Sigen Lan; Jieqiong Liu; Zhulin Yang
Journal:  Diagn Pathol       Date:  2011-10-21       Impact factor: 2.644

9.  REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer.

Authors:  A Sekikawa; H Fukui; X Zhang; T Maruo; T Tsumura; Y Okabe; T Wakasa; Y Osaki; T Chiba; T Tomita; T Oshima; J Watari; H Miwa
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

Review 10.  The role of Reg IV in colorectal cancer, as a potential therapeutic target.

Authors:  Yiwang Hu; Chi Pan; Jiyi Hu; Suzhan Zhang
Journal:  Contemp Oncol (Pozn)       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.